NFE2L2 and diabetes mellitus: 2SC has been described in aging and diabetes, and its functional consequences have been reported for GAPDH and adiponectin in addition to the KEAP1/NRF2 pathway (Adam et al., 2011; Frizzell et al., 2009; Thomas et al., 2012).